Smith & Nephew plc (SNN)

NYSE: SNN · IEX Real-Time Price · USD
27.81
-0.23 (-0.82%)
Mar 28, 2023, 4:00 PM EDT - Market closed
-0.82%
Market Cap 12.14B
Revenue (ttm) 5.22B
Net Income (ttm) 223.00M
Shares Out 436.68M
EPS (ttm) 0.51
PE Ratio 54.58
Forward PE 16.50
Dividend $0.38 (1.38%)
Ex-Dividend Date Sep 29, 2022
Volume 547,788
Open 27.81
Previous Close 28.04
Day's Range 27.67 - 27.96
52-Week Range 21.78 - 34.12
Beta 0.35
Analysts Buy
Price Target 33.22 (+19.45%)
Earnings Date Feb 28, 2023

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform m... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 16, 1999
Employees 18,000
Stock Exchange NYSE
Ticker Symbol SNN
Full Company Profile

Financial Performance

In 2022, Smith & Nephew's revenue was $5.22 billion, an increase of 0.06% compared to the previous year's $5.21 billion. Earnings were $223.00 million, a decrease of -57.44%.

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for SNN stock is "Buy." The 12-month stock price forecast is $33.22, which is an increase of 19.45% from the latest price.

Price Target
$33.22
(19.45% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Smith & Nephew's (SNN) CIT Technology Favored by New Study

Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.

4 days ago - Zacks Investment Research

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

LONDON , March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsu...

5 days ago - PRNewsWire

Smith & Nephew (SNN) Simplifies ACL Surgery With New Offers

Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.

2 weeks ago - Zacks Investment Research

Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting

LONDON , March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural innovations for j...

2 weeks ago - PRNewsWire

Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting

An uncompromising commitment to freedom of movement LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils "Precision in Motion"...

3 weeks ago - PRNewsWire

Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction

LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the n...

3 weeks ago - PRNewsWire

Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation

LONDON , March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient...

3 weeks ago - PRNewsWire

What Makes Smith & Nephew (SNN) a New Buy Stock

Smith & Nephew (SNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago - Zacks Investment Research

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System

Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON , Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ...

2 months ago - PRNewsWire

Smith & Nephew Is Reverting to Fair Value

The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging...

2 months ago - GuruFocus

Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution

LONDON , Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hyb...

5 months ago - PRNewsWire

Smith+Nephew first to market with revision knee indication on robotics platform

LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgic...

6 months ago - PRNewsWire

Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies

LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a ...

6 months ago - PRNewsWire

New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months

LONDON , Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, today announces promising new data furthering a number of published studies supporting ...

6 months ago - PRNewsWire

Smith & Nephew: A Medical Equipment Opportunity

FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.

8 months ago - GuruFocus

Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend

LONDON , Aug. 4, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces that the OXINIUM Technology Tour of Change mobile exhibit will make a s...

8 months ago - PRNewsWire

Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting

LONDON , July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robust line-up featuring several of its advanced joint repair soluti...

9 months ago - PRNewsWire

Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care

LONDON , July 12, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND COMPASS™ Clinical Support App. The WOUND COMPASS ...

9 months ago - PRNewsWire

Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System

LONDON , June 30, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementle...

9 months ago - PRNewsWire

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

LONDON , June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds International . The...

10 months ago - PRNewsWire

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION

LONDON , June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces that the first total hip arthroplasty (THA) procedure using RI.HIP MODELE...

10 months ago - PRNewsWire

Healiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew

LUGANO, Switzerland--(BUSINESS WIRE)-- #celltherapy--Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the ac...

10 months ago - Business Wire

Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound

Smith & Nephew PLC (NYSE: SNN) posted Q1 revenue of $1.31 billion, up 3.3% on a reported basis (including -2.6% currency effect) and up 5.9% on an underlying basis. Sports Medicine & ENT revenue up 8....

11 months ago - Benzinga

Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors

LONDON , March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in Wound Care Jour...

1 year ago - PRNewsWire

Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at AAOS 2022 Annual Meeting

LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will it showcase its latest innovations for Orthopaedic Reconstructi...

1 year ago - PRNewsWire